AUDREY CORVINO: Open Payments
NPI 1699384586 · AVON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,480 in 78 payments from 18 companies in 2025. Trend: 2023 $80 · 2024 $108 · 2025 $1,480
Food & beverage: $1,480
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $470 |
| Lilly USA, LLC | 13 | $245 |
| AstraZeneca Pharmaceuticals LP | 6 | $143 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $114 |
| PFIZER INC. | 4 | $70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
| GlaxoSmithKline, LLC. | 2 | $57 |
| Amneal Pharmaceuticals LLC | 2 | $45 |
| Ardelyx, Inc. | 2 | $43 |
| Amgen Inc. | 2 | $41 |
Products named: JARDIANCE, UBRELVY, AIRSUPRA, QULIPTA, XIFAXAN, VRAYLAR, SHINGRIX, MOUNJARO.
Industry payments across CT — which companies pay providers there.
